Safety Assessment of Inactivated Whole Virion Booster Vaccine against the SARS-CoV-2 Virus (BelCovidVac) in Immunized Study Subjects aged 18 to 60 Years (day 28)
Relevance. According to the World Health Organization (WHO), it is not yet possible to effectively stop the spread of new strains of coronavirus [1]. At the same time, most experts and analysts in the field of medicine publicly admit that at the moment vaccination is the most powerful weapon in the...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Numikom LLC
2024-07-01
|
| Series: | Эпидемиология и вакцинопрофилактика |
| Subjects: | |
| Online Access: | https://www.epidemvac.ru/jour/article/view/2019 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|